Sunitinib in breast cancer: Friend or foe

Saved in:
Bibliographic Details
Published in:Breast (Edinburgh) 2009-08, Vol.18 (4), p.211-212
Main Authors: Cardoso, Fatima, Senkus-Konefka, Elzbieta
Format: Article
Language:English
Subjects:
Angiogenesis Inhibitors - administration & dosage
Antineoplastic Agents - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Breast Neoplasms - drug therapy
Breast Neoplasms - pathology
Female
Hematology, Oncology and Palliative Medicine
Humans
Indoles - administration & dosage
Pyrroles - administration & dosage
Taxoids - administration & dosage
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c462t-c4241b6e9217b0a022b6f98d895b3742e0646a414a8b8c37588f5b119bd6931c3
cites cdi_FETCH-LOGICAL-c462t-c4241b6e9217b0a022b6f98d895b3742e0646a414a8b8c37588f5b119bd6931c3
container_end_page 212
container_issue 4
container_start_page 211
container_title Breast (Edinburgh)
container_volume 18
creator Cardoso, Fatima
Senkus-Konefka, Elzbieta
description
doi_str_mv 10.1016/j.breast.2009.07.006
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734043988</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960977609000848</els_id><sourcerecordid>734043988</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-c4241b6e9217b0a022b6f98d895b3742e0646a414a8b8c37588f5b119bd6931c3</originalsourceid><addsrcrecordid>eNqFkUtr3DAURkVpaCaPf1CCd6GLca4e1qOLQghNWhjIYpK1kORr0NRjJ5IdyL-vBg8UsulG2pz7Xe75CPlKoaZA5c2u9gldnmoGYGpQNYD8RFa04WzNQcNnsgIjYW2UkqfkLOcdFJBL_YWcUqOEkKxZkW_beYhTHKKv4lAtiVVwQ8D0vbpPEYe2GlPVjXhBTjrXZ7w8_ufk-f7n092v9ebx4ffd7WYdSuJUXiaol2gYVR4cMOZlZ3SrTeO5EgxBCukEFU57HbhqtO4aT6nxrTScBn5OrpfclzS-zpgnu485YN-7Acc5W8UFCG60LqRYyJDGnBN29iXFvUvvloI9OLI7u1xkD44sKFsclbGr44LZ77H9N3SUUoAfC4DlzLeIyeZQRARsY8Iw2XaM_9vwMSD0RXFw_R98x7wb5zQUhZbazCzY7aGnQ01gSkVaaP4XdYyLwA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734043988</pqid></control><display><type>article</type><title>Sunitinib in breast cancer: Friend or foe</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Cardoso, Fatima ; Senkus-Konefka, Elzbieta</creator><creatorcontrib>Cardoso, Fatima ; Senkus-Konefka, Elzbieta</creatorcontrib><identifier>ISSN: 0960-9776</identifier><identifier>EISSN: 1532-3080</identifier><identifier>DOI: 10.1016/j.breast.2009.07.006</identifier><identifier>PMID: 19744625</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Angiogenesis Inhibitors - administration &amp; dosage ; Antineoplastic Agents - administration &amp; dosage ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Breast Neoplasms - drug therapy ; Breast Neoplasms - pathology ; Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Indoles - administration &amp; dosage ; Pyrroles - administration &amp; dosage ; Taxoids - administration &amp; dosage</subject><ispartof>Breast (Edinburgh), 2009-08, Vol.18 (4), p.211-212</ispartof><rights>Elsevier Ltd</rights><rights>2009 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-c4241b6e9217b0a022b6f98d895b3742e0646a414a8b8c37588f5b119bd6931c3</citedby><cites>FETCH-LOGICAL-c462t-c4241b6e9217b0a022b6f98d895b3742e0646a414a8b8c37588f5b119bd6931c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19744625$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cardoso, Fatima</creatorcontrib><creatorcontrib>Senkus-Konefka, Elzbieta</creatorcontrib><title>Sunitinib in breast cancer: Friend or foe</title><title>Breast (Edinburgh)</title><addtitle>Breast</addtitle><subject>Angiogenesis Inhibitors - administration &amp; dosage</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - pathology</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Indoles - administration &amp; dosage</subject><subject>Pyrroles - administration &amp; dosage</subject><subject>Taxoids - administration &amp; dosage</subject><issn>0960-9776</issn><issn>1532-3080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFkUtr3DAURkVpaCaPf1CCd6GLca4e1qOLQghNWhjIYpK1kORr0NRjJ5IdyL-vBg8UsulG2pz7Xe75CPlKoaZA5c2u9gldnmoGYGpQNYD8RFa04WzNQcNnsgIjYW2UkqfkLOcdFJBL_YWcUqOEkKxZkW_beYhTHKKv4lAtiVVwQ8D0vbpPEYe2GlPVjXhBTjrXZ7w8_ufk-f7n092v9ebx4ffd7WYdSuJUXiaol2gYVR4cMOZlZ3SrTeO5EgxBCukEFU57HbhqtO4aT6nxrTScBn5OrpfclzS-zpgnu485YN-7Acc5W8UFCG60LqRYyJDGnBN29iXFvUvvloI9OLI7u1xkD44sKFsclbGr44LZ77H9N3SUUoAfC4DlzLeIyeZQRARsY8Iw2XaM_9vwMSD0RXFw_R98x7wb5zQUhZbazCzY7aGnQ01gSkVaaP4XdYyLwA</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Cardoso, Fatima</creator><creator>Senkus-Konefka, Elzbieta</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090801</creationdate><title>Sunitinib in breast cancer: Friend or foe</title><author>Cardoso, Fatima ; Senkus-Konefka, Elzbieta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-c4241b6e9217b0a022b6f98d895b3742e0646a414a8b8c37588f5b119bd6931c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Angiogenesis Inhibitors - administration &amp; dosage</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - pathology</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Indoles - administration &amp; dosage</topic><topic>Pyrroles - administration &amp; dosage</topic><topic>Taxoids - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cardoso, Fatima</creatorcontrib><creatorcontrib>Senkus-Konefka, Elzbieta</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Breast (Edinburgh)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cardoso, Fatima</au><au>Senkus-Konefka, Elzbieta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sunitinib in breast cancer: Friend or foe</atitle><jtitle>Breast (Edinburgh)</jtitle><addtitle>Breast</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>18</volume><issue>4</issue><spage>211</spage><epage>212</epage><pages>211-212</pages><issn>0960-9776</issn><eissn>1532-3080</eissn><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>19744625</pmid><doi>10.1016/j.breast.2009.07.006</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0960-9776
ispartof Breast (Edinburgh), 2009-08, Vol.18 (4), p.211-212
issn 0960-9776
1532-3080
language eng
recordid cdi_proquest_miscellaneous_734043988
source ScienceDirect Freedom Collection 2022-2024
subjects Angiogenesis Inhibitors - administration & dosage
Antineoplastic Agents - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Breast Neoplasms - drug therapy
Breast Neoplasms - pathology
Female
Hematology, Oncology and Palliative Medicine
Humans
Indoles - administration & dosage
Pyrroles - administration & dosage
Taxoids - administration & dosage
title Sunitinib in breast cancer: Friend or foe
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T15%3A59%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sunitinib%20in%20breast%20cancer:%20Friend%20or%20foe&rft.jtitle=Breast%20(Edinburgh)&rft.au=Cardoso,%20Fatima&rft.date=2009-08-01&rft.volume=18&rft.issue=4&rft.spage=211&rft.epage=212&rft.pages=211-212&rft.issn=0960-9776&rft.eissn=1532-3080&rft_id=info:doi/10.1016/j.breast.2009.07.006&rft_dat=%3Cproquest_cross%3E734043988%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-c4241b6e9217b0a022b6f98d895b3742e0646a414a8b8c37588f5b119bd6931c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=734043988&rft_id=info:pmid/19744625&rfr_iscdi=true